Roberta F. Shapiro DO, FAAPM&R: “A New York Doctor’s Path to Panama” – A Stem Cell Therapy Video Lecture

Special Guest Speaker, Roberta F. Shapiro DO, FAAPM&R speaks about: “A New York Doctor’s Path to Panama” at the Stem Cell Institute’s Stem Cell Therapy Public Seminar in New York City on May 17, 2014.

Dr. Shapiro discusses how she discovered the Stem Cell Institute and why she started referring her patients to Panama for stem cell therapy.

Dr. Shapiro operates a private practice for physical medicine and rehabilitation in New York City. Her primary professional activities include outpatient practice focused on comprehensive treatment of acute and chronic musculoskeletal and myofascial pain syndromes using manipulation techniques, trigger point injections, tendon injections, bursae injections, nerve and motor point blocks. Secondary work at her practice focuses on the management of pediatric onset disability.

She is the founder and president of the Dayniah Fund, a non-profit charitable foundation formed to support persons with progressive debilitating diseases who are faced with catastrophic events such as surgery or illness. The Dayniah Fund educates the public about the challenges of people with disabilities and supports research on reducing the pain and suffering caused by disabling diseases and conditions.

Dr. Shapiro serves as assistant clinical professor in the Department of Rehabilitation and Regenerative Medicine at Columbia University Medical Center.

The Lip TV News: Neil Riordan, PhD on Exploring New Stem Cell Treatments for MS, Arthritis, Autism and More

Stem cell treatment and research towards curing illness–from multiple sclerosis to spinal injury–is detailed by Dr. Neil Riordan. The American medical industry, obstructions to research in the states, misconceptions about stem cells, and the details about the treatment process are explained–and we look at video of patient recovery and speculate at what the future could spell for stem cell treatment and research in this Lip News interview, hosted by Elliot Hill.

GUEST BIO:
Dr. Neil Riordan is the founder and Chairman of Medistem Panama, a leading stem cell laboratory and research facility – located in Panama City. His institute is at the forefront of research of the effects of adult stem cells on the course of several chronic diseases. Dr. Riordan has more than 60 scientific articles in international peer-reviewed journals. In the stem cell arena, he and his colleagues have published more than 20 articles on Multiple Sclerosis, Spinal Cord Injury, Heart Failure, Rheumatoid Arthritis.

Colorado MS patient returning to Panama for more stem cell therapy

By Travis Khachatoorian
Created: Mon, 05 May 2014 10:21:00 MST
Updated: Mon, 05 May 2014 11:27:10 MST

CLIFTON, Colo. – Even with all the advances in medical sciences over the years, multiple sclerosis remains mysterious in both causes and symptoms. There is no known cure for the disease, but one Clifton resident isn’t waiting on the US government anymore and is planning to fly to Panama for a stem cell therapy.

Pam Claypoole was diagnosed with MS almost a decade ago and has slowly lost the feeling in her legs and right arm. She said since the FDA currently doesn’t approve any stem cell therapies for her disease, she’s planning a second trip to Panama in hopes to improve her condition.

Claypoole said she’s made one trip to the Stem Cell Institute in Panama more than a year ago and was amazed by the effects.

“I felt it made a big difference for me right away,” said Claypoole. “My walking was better, the feeling in my feet was better, I had more energy.”

She emphasized her treatment doesn’t involve unborn fetus stem cells but rather the stem cells taken from healthy birthed babies umbilical cords.

Her family is currently planning a live auction on May 14th at the Western Slope Cattleman’s Livestock Auction in Loma. The event starts at 6 pm, and they’re hoping to collect $20,000 dollars to fund Pam’s therapy in Central America.

more…

Stem cell therapy for traumatic brain injury – Oswaldo Tapanes

Oswaldo Tapanes received multiple injections of human umbilical cord-derived mesenchymal stem cells and his own bone marrow-derived stem cells over the course of a month both intrathecally (into the spinal fluid) and intravenously at the Stem Cell Institute in Panama. Here is what Mr. Tapanes had to day about his progress thus far:

My name is Oswaldo Tapanes. I have a traumatic brain injury; diagnosed in June 2005.

What symptoms did you have before stem cell therapy?

I couldn’t move my left arm. My vision was pretty bad. My speech is worse than it is now. I could only make sounds. My balance was very, very bad and that’s about it.

What improvements have you noticed since your stem cell treatments?

My speech is better. My eyesight is better. My arm coordination is better. My balance overall and better overall well-being.

How has this treatment changed your life?

It improved my quality of life, so much so that I’ve returned now for a second treatment.

What would you tell others who are considering this treatment?

I would say obviously, do your own research but from my point of view, it’s very safe. The medical science is explained. Everything is there on the web site if you look at it and do your homework. I wouldn’t hesitate coming. If I knew before, I would have came earlier.

Heart failure patient has 3 normal EKGs after stem cell therapy

I was diagnosed 20 years ago. My heart was stopped up. I have 11 stents in my heart. When they put in (stents) nine, ten and eleven they blocked an artery and caused me to have a heart attack. Then 4 years later, I went to the doctor and he did an EKG and he said he needed to do a nuclear scan. That was in May 2011. In July of 2011 he did a nuclear scan and then called me and told me there was nothing else he could do for me.

A friend of mine in Corpus Christi told me about stem cells in Panama. So I checked into it and I came down in October of 2011 and had a treatment.

[Mr. Gray received multiple doses of human umbilical cord-derived mesenchymal stem cells over the course of several days.]

I didn’t feel anything for 30 days. Then I started feeling better and really felt good. I went to the doctor in January of 2012. He did an EKG and walked in and said, “What have you done?” I said, “What are you talking about?” He said, “You have a normal EKG. You’ve never had one of these before.“ So I asked my wife, “Do you think I ought to tell him?” This was in St. Dominic’s Hospital in Jackson Mississippi; the one that had caused me to have the heart attack. So I asked her, “Reckon I ought to tell him I had got stem cells?” She said, “Yes.” So I told him. He looked like I had cut his throat. He was white as a sheet and he wanted to know, “How did they do it?” and I told him.

Since then I have had 3 normal EKGs. The last one was about 2 months ago.
Well, I had another treatment about 11 months later and it fixed my kidneys the second time. The first time it fixed my heart. It didn’t do anything else but then the second time it fixed my kidneys. I had horse shoe kidneys and I was operated on when I was 33 years old, 35 years old and now I’m 69. My kidney had grown together and my kidneys have been bad my whole life but now they’re fine.

Professor Arnold Caplan discusses mesenchymal stem cell therapy for multiple sclerosis

Professor Caplan is “The father of the mesenchymal stem cell (MSC)”. In this clip, he describes a mouse experiment using human MSCs in a mouse model of MS. The experiment shows that it’s possible to place human cells in mice that have normal immune systems. He continues to discuss the astounding results.

Umbilical Cord Stem Cells: Regeneration, Repair, Inflammation and Autoimmunity – Neil Riordan PhD (Part 2 of 2)

In part 2, Dr. Riordan discusses how mesenchymal stem cells can affect tissue repair in spinal cord injury and in heart failure; benefit to heart is not the actual MSCs modeling new tissue. It is due to the trophic effects of MSC secretions; In rats, severed spinal cords re-grew after MSCs were implanted but the human MSCs did not form new cord tissue. The trophic factors secreted by the MSCs enable the spinal cord to repair itself.; Trophic factors from MSCs modulate the immune system by blocking clonal expansion of cytotoxic T-cells; There are 35 ongoing clinical trials using mesenchymal stem cells for autoimmune diseases; Safety of donor MSCs; Every mother has MSCs from each baby she has carried; Mothers have a lower incidence of autoimmune disease; Lifespan of mothers increased linearly with each child up to 14; There are 85 ongoing clinical trials using donor MSCs. Allogeneic MSCs from bone marrow have been approved in Canada and New Zealand to treat graft vs. host disease; limbal cells used in corneal transplants are MSCs; MSCs are useful in preventing donated organ rejection; glioma growth was found to be inhibited by MSCs; MSCs eliminated breast cancer in rats.

Umbilical Cord Mesenchymal Stem Cells: Regeneration, Repair, Inflammation and Autoimmunity – Neil Riordan, PhD (Part 1 of 2)

Neil Riordan, PhD is the Founder of the Stem Cell Institute in Panama. He is also the Co-Founder of Medistem Inc in San Diego and the current President of Medistem Panama. Dr. Riordan is speaking at a Stem Cell Institute patient outreach event held in Miami in May 2013.
In part 1, Dr. Riordan discusses the background of Medistem Panama and the Stem Cell Institute (SCI) in Panama. He presents the types of stem cells used at SCI: Patient’s own bone marrow, Patient’s own fat tissue and umbilical cord mesenchymal stem cells donated from live, healthy births. Dr. Riordans goes on to discuss: collaborations with UC San Diego, Indiana University, University of Utah and University of Western Ontario; patents and publications; Medistem Panama lab, clean rooms and equipment; Why the Stem Cell Institute is in Panama; Panamanian stem cell laws; What are mesenchymal stem cells (MSCs) ?, mesenchymal stem cell homing, how MSCs induce repair, how MSCs modulate the immune system, young vs. old MSCs, Are MSCs safe?; MSCs are actually pericytes. They are found throughout the body in all vascular tissues around blood vessels, bone marrow, umbilical cord, placental tissue, menstrual blood and teeth; Stem Cell Institute’s source of umbilical cord MSCs: live, healthy birth, mother screened for medical history, consent from family for donation, mother tested for infectious diseases, cord tested for infectious diseases and sterility; the mesengenic process; how pericytes respond to injury and form “medicinal MSCs”; MSCs are anti-apoptotic, anti-scaring, angiogenic, and mitotic.; MSCs are also immunomodulatory; MSC homing in rats; Human MSCs decline drastically with age; Stem Cell Institute uses umbilical cord-derived MSCs because they are non-tumorigenic, very robust – high number of doublings, faster doubling time,; What does ‘doubling’ mean?; Effects of aging on MSCs.

VIDEO – The Science of Mesenchymal Stem Cells and Regenerative Medicine – Arnold Caplan PhD (Part 7 of 7)

In this final segment, Prof. Caplan discusses: Mesenchymal stem cells make anti-bacterial molecules, How retro-orbital injections of human MSCs cure mice with cystic fibrosis infected by pneumonia aeruginosa 70% of the time, The process by which MSCs kill bacteria in the body, Clinical trial for using MSCs to treat sepsis, “MSCs are drug stores for sites of injury or inflammation. They are site regulated, multi-drug delivery vehicles”, MSC transitions: ostegenic, trophic and immunomodulatory, MSCs are not stromal cells. They are not part of the connective tissue, The name of the MSC has changed. It is a “Medicinal Signaling Cell” and has nothing whatsoever to do with “stem-ness”, Cell plasticity, transdifferentiation in the mesengenic process.

VIDEO – The Science of Mesenchymal Stem Cells and Regenerative Medicine – Arnold Caplan PhD (Part 6)

In part 6, Prof. Caplan discusses Trophic properties of mesenchymal stem cells; MSCs for heart disease; MSCs homing to heart injury site and also to skin incision site; MSCs limit left ventricular thinning following infarction; Trophic properties of MSCs: anti-apoptotic, anti-fibrotic, anti-scarring, angiogenic, mitotic; phase 1 data for allogeneic MSCs show fewer arrhythmias, prompt heart rate recovery, and improved lung function; autologous adipose tissue-derived stromal vascular fraction for treatment of chronic heart disease; Active mesenchymal stem cell clinical trials around the world; Induction therapy with autologous MSCs in kidney transplants; MSCs can coax neural stem cells to become oligodendrocytes, curing mice with MS using allogeneic human MSCs.